Comparative analysis of [18F]F-FAPI PET/CT, [18F]F-FDG PET/CT and magnetization transfer MR imaging to detect intestinal fibrosis in Crohn's disease: A prospective animal model and human cohort study.

Li, Zhoulei; Chen, Zhihui; Zhang, Ruonan; Lin, Jinjiang; Huang, Siyun; Shi, Kuangyu; Shen, Xiaodi; Xiang, Zijun; Wang, Xinyue; Huang, Lili; Zheng, Qingzhu; Liu, Xubin; Tan, Jinyu; Chen, Minhu; Li, Ziping; Mao, Ren; Zhang, Xiangsong; Wang, Yangdi; Song, Xinming and Li, Xuehua (2024). Comparative analysis of [18F]F-FAPI PET/CT, [18F]F-FDG PET/CT and magnetization transfer MR imaging to detect intestinal fibrosis in Crohn's disease: A prospective animal model and human cohort study. European journal of nuclear medicine and molecular imaging, 51(7), pp. 1856-1868. Springer 10.1007/s00259-024-06644-7

[img] Text
s00259-024-06644-7.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (5MB)

PURPOSE

Accurately and early detection of intestinal fibrosis in Crohn's disease (CD) is crucial for clinical management yet remains an unmet need. Fibroblast activation protein inhibitor (FAPI) PET/CT has emerged as a promising tool to assess fibrosis. We aimed to investigate the diagnostic capability of [18F]F-FAPI PET/CT in detecting intestinal fibrosis and compared it with[18F]F-FDG PET/CT and magnetization transfer MR imaging (MTI).

METHODS

Twenty-two rats underwent TNBS treatment to simulate fibrosis development, followed by three quantitative imaging sessions within one week. Mean and maximum standardized uptake values (SUVmean and SUVmax) were calculated on[18F]F-FAPI and [18F]F-FDG PET/CT, along with normalized magnetization transfer ratio on MTI. Intestinal fibrosis was assessed pathologically, with MTI serving as imaging standard for fibrosis. The diagnostic efficacy of imaging parameters in fibrosis was compared using pathological and imaging standards. Ten patients with 34 bowel strictures were prospectively recruited to validate their diagnostic performance, using the identical imaging protocol.

RESULTS

In CD patients, the accuracy of FAPI uptake (both AUCs = 0.87, both P ≤ 0.01) in distinguishing non-to-mild from moderate-to-severe fibrosis was higher than FDG uptake (both AUCs = 0.82, P ≤ 0.01) and comparable to MTI (AUCs = 0.90, P ≤ 0.001). In rats, FAPI uptake responded earlier to fibrosis development than FDG and MTI; consistently, during early phase, FAPI uptake showed a stronger correlation (SUVmean: R = 0.69) with pathological fibrosis than FDG (SUVmean: R = 0.17) and MTI (R = 0.52).

CONCLUSION

The diagnostic efficacy of [18F]F-FAPI PET/CT in detecting CD fibrosis is superior to [18F]F-FDG PET/CT and comparable to MTI, exhibiting great potential for early detection of intestinal fibrosis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Shi, Kuangyu

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1619-7089

Publisher:

Springer

Language:

English

Submitter:

Pubmed Import

Date Deposited:

15 Feb 2024 09:31

Last Modified:

31 May 2024 00:13

Publisher DOI:

10.1007/s00259-024-06644-7

PubMed ID:

38355741

Uncontrolled Keywords:

Crohn’s disease Fibroblast activation protein Fibrosis Positron emission tomography

BORIS DOI:

10.48350/192923

URI:

https://boris.unibe.ch/id/eprint/192923

Actions (login required)

Edit item Edit item
Provide Feedback